E

Enlivex Therapeutics Ltd
D

ENLV

0.98510
USD
0.02
(1.56%)
مغلق
حجم التداول
400
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
23,930,870
أصول ذات صلة الأخبار المقالات

العنوان: Enlivex Therapeutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.